98
Participants
Start Date
May 31, 2010
Primary Completion Date
September 30, 2010
Study Completion Date
September 30, 2010
HPN-100
single oral dose of 9 mL HPN-100 given via syringes 3 times daily for 3 days
HPN-100 or Placebo
single oral dose of 12 mL HPN-100 given via syringes 3 times daily for 3 days
Placebo
single oral (by mouth) dose of 9 mL placebo given via syringes 3 times daily for 3 days
Moxifloxacin
single oral 400-mg dose on study Day 3
HPN-100
single oral dose of 6 mL HPN-100 and 3 mL placebo given via syringes 3 times daily for 3 days
HPN-100
single oral dose of 9 mL HPN-100 given via syringes 3 times daily for 3 days
Covance Clinical Pharmacology, Inc., Madison
Lead Sponsor
Amgen
INDUSTRY